Program
09:00 Welcome
Chairpersons: John Chapman, Bryan Brewer and Kaare R. Norum
LCAT patients and treatment
09:10 Kaare R. Norum
The Early History of LCAT and familial LCAT Deficiency
09:30 Helena Miettinen
Finnish patients with LCAT deficiency
09:50 Erik H. Strøm
Kidney Biopsies after Kidney Transplantation in a Norwegian Patient with familial LCAT Disease
Coffee break
10:20 Bruno E P Balbo and Carlos Sampaio
Brief history of LCAT deficiency in Hospital das Clínicas
10:50 Alan Remaley
Treatment of LCAT Deficiency Patients with recombinant LCAT
11:20 Ingrid Wiig
Norwegian National Advisory Unit on Rare Disorders.
Lunch
LCAT Structure and Function
12:30 Jan Albert Kuivenhoven
LCAT and Atherosclerosis
13:00 Laura Calabresi
Genetic LCAT deficiency and atherosclerosis
13:30 John Tesmer
Structure and function of LCAT
14:00 Kelly Manthei
Studies on LCAT structure
14.15 Mingyue Zhou
LCAT Therapeutics Innovations
Coffee
15:00 Sotirios Karathanasis
Acute LCAT infusion increase macrophage-specific cholesterol efflux in LCAT deficient human ApoA-1 transgenic mice
15:30 Dominic Ng
Non-Classical Metabolic Phenotypes of LCAT Deficiency – Lessons from Murine Models
16:00 Terje R. Pedersen
Future Pharmaceutical Agents for Treatment of Dyslipidemia
16:30 Rune Blomhoff
General discussion and closing remarks
Registration
The registration is now closed, and we can no longer offer lunch to new participants. The lectures are still open to all interested parties.